Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Somlak Vanavanan"'
Autor:
Krittika Saranburut, Prin Vathesatogkit, Nisakron Thongmung, Anchalee Chittamma, Somlak Vanavanan, Tuangrat Tangstheanphan, Piyamitr Sritara, Chagriya Kitiyakara
Publikováno v:
BMC Nephrology, Vol 18, Iss 1, Pp 1-12 (2017)
Abstract Background Asians have among the highest prevalence of chronic kidney disease (CKD) or end-stage renal disease in the world. A risk score capable of identifying high risk individuals at the primary care level could allow targeted therapy to
Externí odkaz:
https://doaj.org/article/6eba6b85efe344ada1996b62a1d01c88
Autor:
Amnuay Sirisopha, Somlak Vanavanan, Anchalee Chittamma, Bunyong Phakdeekitcharoen, Ammarin Thakkinstian, Amornpan Lertrit, Nuankanya Sathirapongsasuti, Chagriya Kitiyakara
Publikováno v:
International Journal of Nephrology, Vol 2016 (2016)
Urine neutrophil gelatinase-associated lipocalin (NGAL) is widely used as a biomarker for acute kidney injury. Cross-sectional studies have shown that NGAL may be elevated in glomerular diseases, but there is limited information on the value of NGAL
Externí odkaz:
https://doaj.org/article/69164286139c4537907faf8164a0fab6
Publikováno v:
Circulation. 144
Introduction: In European countries, hs-cTnI is approved for risk stratification in general population. Whether this indication can be applied to Thai population is unknown. We test the utility of hs-cTnI as a risk stratification tool for incident ca
Autor:
Pornpen Srisawasdi, Martin H. Kroll, Chonlaphat Sukasem, Apichaya Puangpetch, Chalitpon Na Nakorn, Suweejuk Punprasit, Napa Jiratjintana, Somlak Vanavanan, Weerapon Unaharassamee
Publikováno v:
Pharmacogenomics and Personalized Medicine. 12:155-166
Objective To determine whether genetic polymorphisms related to pharmacodynamics with metabolic adverse effects, namely leptin promoter (LEP) rs7799039, leptin receptor rs1137101, dopamine D2 rs4436578, serotonin 5-HT2A rs6313, and serotonin 5-HT2C r
Autor:
Somlak Vanavanan, Chalitpon Na Nakorn, Pornpen Srisawasdi, Charungthai Dejthevaporn, Anchalee Chittamma, Martin H. Kroll, Punyanuch Rodcharoen, Chonlaphat Sukasem
Publikováno v:
Pharmacogenomics and Personalized Medicine
Pornpen Srisawasdi,1 Punyanuch Rodcharoen,1 Somlak Vanavanan,1 Anchalee Chittamma,1 Chonlaphat Sukasem,2 Chalitpon Na nakorn,2 Charungthai Dejthevaporn,3 Martin H Kroll4 1Division of Clinical Chemistry, Department of Pathology, Faculty of Medicine, R
Autor:
Khanat Kruthkul, Mana Rochanawutanon, Somlak Vanavanan, Pornpen Srisawasdi, Martin H. Kroll, Nalinee Kumproa
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 11:241-253
Somlak Vanavanan,1 Pornpen Srisawasdi,1 Mana Rochanawutanon,2 Nalinee Kumproa,1 Khanat Kruthkul,3 Martin H Kroll4 1Division of Clinical Chemistry, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thaila
Autor:
Yaowaluck Hongkaew, Chonlaphat Sukasem, Somlak Vanavanan, Natchaya Vanwong, Martin H. Kroll, Penkhae Limsila, Nattawat Ngamsamut, Apichaya Puangpetch, Boontarika Intachak, Pornpen Srisawasdi
Publikováno v:
Clinical Biochemistry. 50:678-685
To evaluate the influence of dose and duration of risperidone treatment on cardiovascular and diabetes risk biomarkers in children and adolescents with autistic spectrum disorders (ASDs).In this cross-sectional analysis, a total of 168 ASDs patients
Autor:
Somlak Vanavanan, Sukit Yamwong, Krittika Saranburut, Prin Vathesatogkit, Sayan Cheepudomwit, Piyamitr Sritara, Chagriya Kitiyakara, Tawatchai Akrawichien, Anchalee Chittamma
Publikováno v:
Nephrology. 21:678-686
Aim There are limited data on the risks of chronic kidney disease (CKD) in Southeast Asian populations. Several GFR estimating equations have been developed in diverse Asian populations, but they produce markedly discrepant results. We investigated t
Autor:
Somlak Vanavanan, Chagriya Kitiyakara, Suchin Worawichawong, Piyanuch Radinahamed, Aumporn Nampoon, Anchalee Chittamma, Dittapol Muntham, Amornpan Lertrit
Publikováno v:
International Journal of Nephrology and Renovascular Disease
Amornpan Lertrit,1 Suchin Worawichawong,2 Somlak Vanavanan,2 Anchalee Chittamma,2 Dittapol Muntham,3 Piyanuch Radinahamed,1 Aumporn Nampoon,4 Chagriya Kitiyakara1 1Department of Medicine, 2Department of Pathology, Faculty of Medicine, Ramathibodi Hos
Autor:
Chagriya Kitiyakara, Prin Vathesatogkit, Anchalee Chittamma, Piyamitr Sritara, Somlak Vanavanan, Krittika Saranburut, Kobkiat Donsakul, Nisakorn Thongmung
Publikováno v:
Journal of Epidemiology and Community Health. :jech-2019
BackgroundThere is limited information on the role of low socioeconomic status (SES) in the development of new chronic kidney disease (CKD) in the general population, especially from developing countries. This study will test the hypothesis that low